Treatment of chronic or relapsing COVID-19 in immunodeficiency (2022)
Attributed to:
Blood-brain barrier dysfunction and risk of dementia following blood-stream infections
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jaci.2021.10.031
PubMed Identifier: 34780850
Publication URI: http://europepmc.org/abstract/MED/34780850
Type: Journal Article/Review
Parent Publication: Journal of Allergy and Clinical Immunology
Issue: 2
ISSN: 0091-6749